Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
The FDA has approved a new oral formulation to help reduce fatal medication errors in improving outcome for patients with subarachnoid hemorrhage.
The FDA has accepted the Biologics License Application for Eloctate, a first in class recombinant factor VIII Fc fusion protein for hemophilia A treatment.
For patients requiring aortic valve replacement, lower-dose warfarin after implantation with an approved mechanical valve prosthesis is safe and effective, with a lower bleeding risk than with standard-dose anticoagulant therapy.
Simple lifestyle changes, including exercising and maintaining a healthy body mass index, may reduce the risk of blood clots.